Document:

Form of Stock Option Award Letter for February 2007 Awards

 Exhibit 10.2 
 [FORM EMPLOYEE SPECIAL LONG-TERM 
 NQ STOCK OPTION AWARD LETTER] 
 [WESTLAKE LETTERHEAD] 
 March
    , 2007 
 [Name] 
 [Address] 
 [Address] 
 Dear
                                : 
 Westlake Chemical Corporation (the “Company”) hereby grants to you a nonqualified option (“Option”), effective February 23, 2007 (the “Award
Date”), to purchase                      shares of common stock of the Company (“Common Stock”) in accordance with the Westlake
Chemical Corporation 2004 Omnibus Incentive Plan (the “Plan”). Your award is more fully described in the attached Appendix A, Terms and Conditions of Special Long-Term Nonqualified Stock Option Award. 
 The price at which you may purchase the shares of Common Stock covered by the Option is $            
(the “Grant Price”). Unless otherwise provided in the attached Appendix A, your Option will expire on the tenth anniversary of the Award Date (the “Expiration Date”), and will vest and become exercisable in installments as
follows (the “Schedule”): 
  

				
	 Vesting Dates
	  	Percentage of Shares
Exercisable	 
	 Initial Vesting Date: February 23, 2012
	  	50	%
	 Final Vesting Date: August 23, 2016
	  	50	%

 You must be in continuous employment with the Company or one of its Subsidiaries (as defined in the Plan) from the
Award Date through each date on which your Option vests in order for your Option to become exercisable on such date. 
 Your award is subject to the terms
and conditions set forth in the enclosed Plan, any additional terms and conditions set forth in the attached Appendix A, and any rules and regulations adopted by the Plan’s Administrator (as defined in the Plan). You have been provided a copy
of the Plan and the Prospectus for the Plan. 
 This award letter and the attachments contain the formal terms and conditions of your award and accordingly
should be retained in your files for future reference. 
 Very truly yours, 
 Enclosures 

 [FORM EMPLOYEE SPECIAL LONG-TERM NQ STOCK OPTION AWARD - APPENDIX A] 
 Appendix A 
 to Award Letter

 dated 
 [March     , 2007] 
 Terms and Conditions of 
 Employee Special Long-Term Nonqualified Stock Option Award 
 The nonqualified stock option (the “Option”) granted to you by Westlake Chemical Corporation (the “Company”) to purchase common stock of the Company (“Common Stock”) is subject to the terms and conditions
set forth in the Westlake Chemical Corporation 2004 Omnibus Incentive Plan (the “Plan”), any rules and regulations adopted by the Administrator (as defined in the Plan), and any additional terms and conditions set forth in this
Appendix A which forms a part of the attached award letter to you (the “Award Letter”). Any terms used in this Appendix A and not defined in the Award Letter or this Appendix A have the meanings set forth in the Plan. In the
event there is an inconsistency between the terms of the Plan and this Appendix A, the terms of the Plan will control. 
  

	1.	Grant Price 

 You may purchase the shares of Common
Stock covered by the Option for the Grant Price stated in your Award Letter. 
  

	2.	Term of Option 

 Your Option expires on the
Expiration Date as defined in your Award Letter. However, your Option will terminate prior to the Expiration Date as provided in Paragraph 6 of this Appendix A upon the occurrence of one of the events described in that paragraph. Regardless of
the provisions of Paragraph 6, in no event can your Option be exercised after the Expiration Date. 
  

	3.	Earn-out of Option 

  

	 	(a)	Unless it becomes vested and exercisable on an earlier date as provided in Paragraph 6 below, your Option will become vested and exercisable in cumulative installments as set forth
in the Schedule in your Award Letter. 

  

	 	(b)	To the extent your Option has become vested and exercisable, you may exercise the Option as to all or any part of the shares covered by the Option, at any time on or before the date
the Option expires or terminates, subject to any limitations imposed by law or by Company policy regarding transactions in Common Stock. 

  

	4.	Exercise of Option 

 Subject to the limitations set
forth in this Appendix A and in the Plan, your Option may be exercised from time to time, in accordance with its terms, by written notice signed and delivered by you or another person entitled to exercise the Option to the General Counsel 

 
of the Company at its principal executive office in Houston, Texas, or as it may hereafter be located, as set forth below. Such written notice shall
(a) state the number of shares of Common Stock with respect to which your Option is being exercised and (b) be accompanied by a wire transfer, cashier’s check, cash, money order or other form of payment deemed acceptable by the
Administrator or its designee and made payable to Westlake Chemical Corporation in the full amount of the Grant Price for any shares of Common Stock being acquired and any appropriate withholding taxes (as provided in Paragraph 7 of this
Appendix A), or by other consideration in the form and manner approved by the Administrator or its designee pursuant to Paragraphs 5 and 7 of this Appendix A. In the alternative, the Administrator or its designee may prescribe other
procedures for exercise of your Option. If any law or regulation requires the Company to take any action with respect to the shares specified in such notice, the time for delivery thereof, which would otherwise be as promptly as possible, shall be
postponed for the period of time necessary to take such action. You shall have no rights of a shareholder with respect to shares of Common Stock subject to your Option unless and until such time as your Option has been exercised and ownership of
such shares of Common Stock has been transferred to you. 
  

	5.	Satisfaction of Grant Price 

  

	 	(a)	Payment of Cash or Common Stock. Your Option may be exercised by payment in cash (including check, bank draft, money order or wire transfer payable to the Company), in Common
Stock, in a combination of cash and Common Stock or in such other manner as the Administrator in its discretion may provide. Payment in Common Stock shall only be permitted if and to the extent authorized by the Administrator.

  

	 	(b)	Payment of Common Stock. The Fair Market Value of any shares of Common Stock tendered as all or part of the Grant Price shall be determined as provided in the Plan. The
certificates evidencing shares of Common Stock tendered must be duly endorsed or accompanied by appropriate stock powers. Only stock certificates issued solely in your name may be tendered in exercise of your Option. Fractional shares may not be
tendered in satisfaction of the Grant Price; any portion of the Grant Price which is in excess of the aggregate Fair Market Value of the number of whole shares tendered must be paid in cash. If a certificate tendered in exercise of the Option
evidences more shares than are required pursuant to the immediately preceding sentence for satisfaction of the portion of the Grant Price being paid in Common Stock, an appropriate replacement certificate will be issued to you for the number of
excess shares. 

  

	 	(c)	 Broker-Assisted Exercise. At your request or the request of another person entitled to exercise this Option, and to the extent permitted by applicable law,
the Administrator in its discretion may selectively approve “cashless exercise” arrangements with a brokerage firm under which such brokerage firm, on behalf of you or such other person exercising the Option, shall pay to the Company or
its designee the Grant Price of the Option or of the portion being exercised, and the Company or its designee, pursuant to an irrevocable notice from you or such other 

  

 2 

	 	 
person exercising the Option, shall promptly deliver the shares being purchased to such firm. 

  

	6.	Termination of Employment 

  

	 	(a)	General. The following rules apply to your Option in the event of your death, disability or other termination of employment. 

  

	 	(i)	Involuntary Termination Without Cause. (1) If your employment with the Company or a Subsidiary is terminated by the Company or any such Subsidiary without Cause prior to
the Initial Vesting Date, your Option shall become exercisable with respect to one-half of the previously unexercisable shares that were scheduled to become exercisable on the Initial Vesting Date, prorated for the number of full months you were
employed from the Grant Date until the date of your termination. (2) If your employment with the Company or a Subsidiary is terminated by the Company or any such Subsidiary without Cause on or after the Initial Vesting Date and prior to the
Final Vesting Date, your Option shall be exercisable to the extent vested on the date of your termination, and shall become exercisable with respect to one-half of the previously unexercisable shares that were scheduled to become exercisable on the
Final Vesting Date, prorated for the number of full months you were employed from the Initial Vesting Date until the date of your termination. (3) To the extent vested, regardless whether vested as a result of your termination of employment or
vested prior thereto, your Option shall remain exercisable until the first to occur of (A) 180 days following your termination date, or (B) the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in
all respects. 

  

	 	(ii)	Voluntary Termination. If you voluntarily terminate employment with the Company or a Subsidiary, including, without limitation, termination of employment due to retirement,
your Option shall be exercisable to the extent vested on the date of your termination. To the extent vested, your Option shall remain exercisable until the first to occur of (A) 30 days following your termination date, or (B) the
Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects. 

  

	 	(iii)	Termination with Cause. If your employment with the Company or a Subsidiary is terminated for Cause, your Option shall immediately terminate and shall no longer be
exercisable. You forfeit any previously vested and unexercised portion of your Option 

  

	 	(iv)	 Termination by Reason of Death. (1) If your employment terminates by reason of death prior to the Initial Vesting Date, your Option shall become
exercisable with respect to the previously unexercisable shares that were scheduled to become exercisable on the Initial Vesting Date, 

  

 3 

	 	 
prorated for the number of full months you were employed from Grant Date until the date of your death. (2) If your employment terminates by reason of
death on or after the Initial Vesting Date and prior to the Final Vesting Date, your Option shall be exercisable to the extent vested on the date of your death, and shall become exercisable with respect to the previously unexercisable shares that
were scheduled to become exercisable on the Final Vesting Date, prorated for the number of full months you were employed from the Initial Vesting Date until the date of your death. (3) To the extent vested, regardless whether vested as a result
of your termination of employment by reason of death or vested prior thereto, your Option will remain exercisable until the first to occur of (A) one year after the date of your termination by reason of death, or (B) the Expiration Date.
Upon expiration of the foregoing period, your Option shall terminate in all respects. 

  

	 	(v)	Termination by Reason of Disability. (1) If your employment terminates by reason of total and permanent disability (as determined by the Administrator) prior to the
Initial Vesting Date, your Option shall become exercisable with respect to the previously unexercisable shares that were scheduled to become exercisable on the Initial Vesting Date, prorated for the number of full months you were employed from the
Grant Date until the date of your termination. (2) If your employment terminates by reason of total and permanent disability (as determined by the Administrator) on or after the Initial Vesting Date and prior to the Final Vesting Date, your
Option will be exercisable to the extent vested on the date of your termination and shall become exercisable with respect to the previously unexercisable shares that were scheduled to become exercisable on the Final Vesting Date, prorated for the
number of full months you were employed from the Initial Vesting Date until the date of your termination. (3) To the extent vested, regardless whether vested as a result of your termination of employment or vested prior thereto, your Option
will remain exercisable until the first to occur of (A) 180 days after the date of your termination, or (B) the Expiration Date. Upon expiration of the foregoing period, your Option shall terminate in all respects.

  

	 	(vi)	Adjustments by the Administrator. The Administrator may, in its sole discretion, exercised before or after your termination of employment, declare all or any portion of your
Option immediately vested and exercisable and/or permit all or any part of your Option to remain exercisable for such period designated by it after the time when the Option would have otherwise terminated as provided in the applicable portion of
this Paragraph 6(a), but not beyond the Expiration Date of your Option. 

  

	 	(b)	Administrator Determinations. The Administrator shall have absolute discretion to determine the date and circumstances of termination of your employment, and its
determination shall be final, conclusive and binding upon you. 

  

 4 

	 	(c)	Cause. For purposes of this Appendix A, Cause shall mean any of the following: 

  

	 	(i)	your conviction by a court of competent jurisdiction of any felony or a crime involving moral turpitude; 

  

	 	(ii)	your knowing failure or refusal to follow reasonable instructions given to you on behalf of the Company or reasonable policies, standards and regulations of the Company or any
Subsidiary; 

  

	 	(iii)	your continued failure or refusal to faithfully and diligently perform the usual, customary duties of your employment with the Company or any Subsidiary; 

 

	 	(iv)	continuously conducting yourself in an unprofessional, unethical or immoral manner; or 

  

	 	(v)	any fraudulent conduct or conduct which discredits the Company or any Subsidiary or is detrimental to the reputation, character and standing of the Company or any Subsidiary.

  

	7.	Tax Consequences and Withholding 

  

	 	(a)	You are urged to consult your own tax advisor regarding the application of the tax laws to your particular situation. 

  

	 	(b)	The Option is not intended to be an “incentive stock option,” as defined in Section 422 of the Code. 

  

	 	(c)	You must make arrangements satisfactory to the Company to satisfy any applicable federal, state or local withholding tax liability arising from the grant or exercise of your Option.
You can either make a cash payment to the Company of the required amount or you can elect to satisfy your withholding obligation by having the Company retain shares of Common Stock having a Fair Market Value (as prescribed by the Plan) equal to the
amount of your withholding obligation from the shares otherwise deliverable to you upon the exercise of your Option. You may not elect to have the Company withhold shares of Common Stock having a Fair Market Value in excess of the minimum statutory
withholding tax liability. 

  

	8.	Restrictions on Resale 

 There are no restrictions
imposed by the Plan on the resale of shares of Common Stock acquired under the Plan. However, under the provisions of the Securities Act of 1933 (the “Securities Act”) and the rules and regulations of the Securities and Exchange
Commission (the “SEC”), resales of shares acquired under the Plan by certain officers and directors of the Company who may be deemed to be “affiliates” of the Company must be made pursuant to an appropriate effective registration
statement filed with the SEC, pursuant to the provisions of Rule 144 issued under the Securities Act, or pursuant 

  

 5 

 
to another exemption from registration provided in the Securities Act. At the present time, the Company does not have a currently effective registration
statement pursuant to which such resales may be made by affiliates. There are no restrictions imposed by the SEC on the resale of shares acquired under the Plan by persons who are not affiliates of the Company. However, the timing of sales of shares
may be restricted by applicable law, and the Company may, from time to time, adopt policies regarding timing of sales of shares by employees. 
  

	9.	Parachute Payments 

 Notwithstanding anything in
this Appendix A to the contrary, if any amounts due you hereunder and under any other plan or program of the Company constitute a “parachute payment,” as such term is defined in Code Section 280G(b)(2), and the amount of the parachute
payment, reduced by all federal, state, and local taxes applicable thereto, including the excise tax imposed pursuant to Code Section 4999, is less than the amount you would receive if you were paid three times your “base amount,” as
defined in Code Section 280G(b)(3), less one dollar, reduced by all federal, state, and local taxes applicable thereto, then the aggregate of the amounts constituting the parachute payment shall be reduced to an amount that will equal three
times your base amount less one dollar. The determinations to be made hereunder shall be made by an accounting firm jointly selected by the Administrator and you and paid by the Company, and which may be the Company’s independent auditors.

  

	10.	Effect on Other Benefits 

 Income recognized by you
as a result of exercise of the Option will not be included in the formula for calculating benefits under any of the Company’s retirement and disability plans or any other benefit plans. 
 If you have any questions regarding your Option or would like to obtain additional information about the Plan or the Administrator, please contact the Senior Vice
President, Administration, or the General Counsel of the Company, Westlake Chemical Corporation, 2801 Post Oak Boulevard, Suite 600, Houston, Texas 77056 (telephone (713) 960-9111). Your Award Letter and this Appendix A contain the formal
terms and conditions of your award and accordingly should be retained in your files for future reference. 
  

 6Amendment No. 2 to Loan and Security Agreement

 Exhibit 10.25 
 AMENDMENT NO. 2 
 TO 
 LOAN AND SECURITY AGREEMENT 
 THIS AMENDMENT
NO. 2 TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into this 11th day of December, 2006, by and between
CYPRESS SEMICONDUCTOR CORPORATION, a Delaware corporation (“Borrower”), and SILICON VALLEY
BANK (“Bank”). Capitalized terms used herein without definition shall have the same meanings given them in the Loan Agreement (as defined below). 
 RECITALS 
 A.
Borrower and Bank have entered into that certain Loan and Security Agreement dated as of September 25, 2003 (as amended to date, the “Loan Agreement”), pursuant to which Bank agreed to extend and make available to
Borrower certain advances of money. 
 B. Borrower desires that Bank amend the Loan Agreement to, among other things, extend the
maturity of such indebtedness and reduce the amount available for borrowing thereunder. 
 C. Subject to the representations and
warranties of Borrower herein and upon the terms and conditions set forth in this Amendment, Bank is willing to amend the Loan Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing Recitals and intending to be legally bound, the
parties hereto agree as follows: 
 1. Amendments to Loan Agreement. 
 1.1 Appendix A. The definition of “Interest Rate” contained in Appendix A to the Loan Agreement is amended and restated in its entirety
as follows: 
 “Interest Rate” shall mean as to: (a) Prime Rate Loans, a rate equal to the Prime Rate; and
(b) LIBOR Rate Loans, a rate of 1.50% per annum in excess of the LIBOR Rate (based on the LIBOR Rate applicable for the Interest Period selected by the Borrower). 
 1.2 Section 13 (Definitions). Section 13 of the Loan Agreement is amended in the following manner: 
 (a) The definitions for the following terms are amended and restated in their entirety as follows: 
 “Committed Revolving Line” is an Advance or Advances not to exceed a principal amount outstanding at any time of
$30,000,000. 

 “Maturity Date” is January 31, 2007. 
 (b) Item (h) of the definition of “Permitted Indebtedness” is amended and restated in its entirety as
follows: 
 “Up to $275,000,000 in principal amount of Indebtedness (and related interest and other amounts) of SunPower Corp. and
guaranties of such Indebtedness by Borrower and its Subsidiaries;” 
 2. BORROWER’S
REPRESENTATIONS AND WARRANTIES. Borrower represents and warrants that: 
 (a) immediately upon giving effect to this Amendment (i) the representations and warranties contained in the Loan Documents are true, accurate and complete in all material respects as of the date hereof (except to the extent
such representations and warranties relate to an earlier date, in which case they are true and correct as of such date), and (ii) no Event of Default has occurred and is continuing; 
 (b) Borrower has the corporate power and authority to execute and deliver this Amendment and to perform its obligations under the Loan Agreement,
as amended by this Amendment; 
 (c) the certificate of incorporation, bylaws and other organizational documents of Borrower
delivered to Bank on the Closing Date remain true, accurate and complete and have not been amended, supplemented or restated and are and continue to be in full force and effect; 
 (d) the execution and delivery by Borrower of this Amendment and the performance by Borrower of its obligations under the Loan Agreement, as
amended by this Amendment, have been duly authorized by all necessary corporate action on the part of Borrower; and 
 (e) this
Amendment has been duly executed and delivered by the Borrower and is the binding obligation of Borrower, enforceable against it in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization,
liquidation, moratorium or other similar laws of general application and equitable principles relating to or affecting creditors’ rights. 
 3. LIMITATION. The amendments and modifications set forth in this Amendment shall be limited precisely as written and shall not be deemed (a) to be a waiver or modification of any other term or
condition of the Loan Agreement or of any other instrument or agreement referred to therein or to prejudice any right or remedy which Bank may now have or may have in the future under or in connection with the Loan Agreement or any instrument or
agreement referred to therein; or (b) to be a consent to any future amendment or modification or waiver to any instrument or agreement the execution and delivery of which is consented to hereby, or to any waiver of any of the provisions
thereof. Except as expressly amended hereby, the Loan Agreement shall continue in full force and effect. 

 4. EFFECTIVENESS. This Amendment shall become effective upon the satisfaction of
all the following conditions precedent: 
 4.1 Amendment. Borrower and Bank shall have duly executed and delivered this Amendment to
Bank and each Guarantor shall have duly executed and delivered a Reaffirmation in the form attached hereto. 
 4.2 Payment of Loan
Fee. Borrower shall have paid Bank a fully-earned, non-refundable loan fee in the amount of $5,000. 
 4.3 Payment of Bank
Expenses. Borrower shall have paid all Bank Expenses (including all reasonable attorneys’ fees and reasonable expenses) incurred through the date of this Amendment. 
 5. COUNTERPARTS. This Amendment may be signed in any number of counterparts, and by different parties hereto in
separate counterparts, with the same effect as if the signatures to each such counterpart were upon a single instrument. All counterparts shall be deemed an original of this Amendment. 
 6. INTEGRATION. This Amendment, the Loan Documents and any documents executed in connection herewith or pursuant
hereto contain the entire agreement between the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, offers and negotiations, oral or written, with respect thereto and no extrinsic evidence whatsoever
may be introduced in any judicial or arbitration proceeding, if any, involving this Amendment or the Loan Documents; except that any financing statements or other agreements or instruments filed by Bank with respect to Borrower shall remain in full
force and effect. 
 7. GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY AND SHALL BE CONSTRUED AND
ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF CALIFORNIA. 
 [Signature page follows.] 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed as of the date first
written above. 
  

							
	 BORROWER:
	 		 	 CYPRESS SEMICONDUCTOR CORPORATION
 a Delaware corporation

				
		 		 	By:	 	 /s/ Neil Weiss

		 		 	Printed Name: Neil Weiss
		 		 	Title: Senior Vice President, Treasurer
			
	 BANK:
	 		 	SILICON VALLEY BANK
				
		 		 	By:	 	 /s/ Tom Smith

		 		 	Printed Name: Tom Smith
		 		 	Title: Senior Relationship Manager

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00118-of-00352.parquet"}]]